Drug intelligence / Profile preview

omega-3 fatty acids (Menoufia University)

Development stage
Unknown
Lead developer
Menoufia University
Modality
Small Molecules
Administration
Oral
01

Overview

Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are long-chain polyunsaturated fatty acids typically derived from fish oil. In the context of sepsis, they are utilized for their potent immunomodulatory and anti-inflammatory properties. These fatty acids function by competitively inhibiting the metabolism of arachidonic acid through the cyclooxygenase (COX) and lipoxygenase (LOX) pathways, thereby reducing the production of pro-inflammatory eicosanoids. Furthermore, they serve as precursors for specialized pro-resolving mediators (SPMs), such as resolvins and protectins, which actively promote the resolution of inflammation. Menoufia University conducted a randomized clinical trial (NCT04121520) to evaluate the efficacy of enteral omega-3 supplementation in reducing organ dysfunction, as measured by SOFA scores, and modulating inflammatory markers in critically ill septic patients.

Other names
fish oiln-3 polyunsaturated fatty acidsn3 polyunsaturated fatty acidsn 3 polyunsaturated fatty acidsn-3 PUFAn3 PUFAn 3 PUFAeicosapentaenoic aciddocosahexaenoic acidEPADHA
02

Targets

ALOX5 (Arachidonate 5-lipoxygenase)PGHS-1 (Prostaglandin G/H Synthase 1)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on omega-3 fatty acids (Menoufia University).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on omega-3 fatty acids (Menoufia University).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call